Boston Scientific (BSX) closed the most recent trading day at $98.50, moving -1.55% from the previous trading session. The stock exceeded the S&P 500, which registered a loss of 4.84% for the day. On ...

New US tariffs could disrupt the medtech industry, impacting major companies like Boston Scientific and Stryker. Read more ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Boston Scientific announced via social media that it has closed the acquisition of Bolt Medical, which recently gained FDA ...

Boston Scientific (NYSE: BSX) announced on social media that it completed its previously announced acquisition of Bolt ...

Boston Scientific just scored a regulatory touchdown with FDA approval for Bolt Medical’s intravascular lithotripsy (IVL) ...

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

Boston Scientific received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA's 510(k) ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A diversified portfolio, strategic acquisitions, and aggressive R&D have driven Boston Scientific's recent ... led a $175M funding round for 4C Medical, a mitral valve developer.